Objectives: To perform molecular characterization of fluoroquinolone-resistant Haemophilus parasuis isolated from South China.
Introduction
Haemophilus parasuis is the causative agent of Glässer's disease, characterized by fibrinous polyserositis, arthritis and meningitis. This disease has produced large losses in the pig industry worldwide. 1 However, no universal vaccines are available to provide effective cross-protective immunity due to serovar diversity and a high number of non-typeable H. parasuis strains. 2 Therefore, antimicrobial agents have become increasingly important to fight this pathogen. Unfortunately, the extended use of fluoroquinolones in veterinary medicine has encouraged an increase in resistance to fluoroquinolones in H. parasuis in many countries. 2, 3 To date, no confirmed interpretive evidence is available to assess the mechanism of fluoroquinolone resistance in H. parasuis.
Therefore, the objective of this work was to investigate the presence of transferable plasmid-mediated quinolone resistance (PMQR) genes, quinolone resistance-determining region (QRDR) mutations and the genetic relatedness of H. parasuis strains in South China to provide a scientific basis for further study of the fluoroquinolone resistance mechanism in H. parasuis. 
Materials and methods

Bacterial isolates
Antimicrobial susceptibility testing
The MIC values of nalidixic acid, ciprofloxacin, levofloxacin, enrofloxacin, norfloxacin and lomefloxacin (National Institute for the Control of Pharmaceutical and Biological Products, Beijing, China) were determined in fastidious medium [tryptic soy broth (TSB) (OXOID, Inc., UK)+5% bovine serum+10 mg/mL NAD (Sigma, Inc., USA)] using custom-designed 96-well microtitre plates. All plates were inoculated following the guidelines of the CLSI (formerly the NCCLS). 4 The microdilution plates were incubated in an atmosphere containing 5% CO 2 at 378C for 24 h. The MIC value was defined as the lowest concentration exhibiting no visible growth. Ranges of susceptibility were recorded along with the MIC that inhibited 50% (MIC 50 ) and 90% (MIC 90 ) of the isolates. The reference strains Actinobacillus pleuropneumoniae ATCC 27090 and Escherichia coli ATCC 25922 served as quality controls for MIC determinations.
Detection of PMQR genes
PCR amplification of PMQR genes [qnrA, qnrB, qnrS, qnrC, qnrD, aac(6 ′ )-Ib-cr and qepA] was performed with ExTaq DNA polymerase (TaKaRa, Inc., China) and previously described primers. 5, 6 Purified PCR products were directly sequenced or cloned into pGEM-T (TaKaRa, Inc., China) and then sequenced (model ABI3730; Applied Biosystems, Inc., USA).
Detection of mutations in QRDRs of gyrA, gyrB, parC and parE
To determine the QRDR mutations in H. parasuis, the 20 isolates that showed higher MICs of nalidixic acid, enrofloxacin, levofloxacin, ciprofloxacin, norfloxacin and lomefloxacin were analysed for gyrA, gyrB, parC and parE sequences using the primers listed in Table S1 (available as Supplementary data at JAC Online). In addition, these genes were also amplified in 15 reference strains that presented lower MICs of the six fluoroquinolones tested. The primers were designed based on the sequences of H. parasuis gyrA, gyrB, parC and parE genes (GenBank accession number NC-011852). The amplified products were then sequenced as described above.
PFGE
To gain insight into the genomic relatedness of H. parasuis strains, macrorestriction CpoI (TaKaRa, Inc., China) analysis resolved by PFGE was applied to 20 resistant strains and 6 PMQR-positive strains. The PFGE typing was carried out using a Chef Mapper electrophoresis system (Bio-Rad, USA). The separation conditions were 2.16 -63.8 s for 21 h. Salmonella enterica serovar Braenderup H9812 served as the size standard, which was digested with XbaI (TaKaRa, Inc., China). Interpretation of the PFGE patterns was accomplished using BioNumerics 4.0 software (Applied Maths Inc., USA).
Results and discussion
Quinolone and fluoroquinolone resistance in H. parasuis A summary of the MIC values of nalidixic acid, enrofloxacin, ciprofloxacin, levofloxacin, norfloxacin and lomefloxacin found in this study is shown in Table S2 (available as Supplementary data at JAC Online). Compared with other studies, we found that different fluoroquinolone susceptibilities of H. parasuis have been observed in different countries over time. 2, 3 Furthermore, the MICs of nalidixic acid and lomefloxacin for H. parasuis were determined for the first time. The MIC 50 and MIC 90 of these antimicrobial agents showed 4-to 8-fold increases compared with previous studies. 2, 3 Our study demonstrating higher MICs for H. parasuis isolated during 2008-2010 in South China should better reflect the current status of quinolone and fluoroquinolone susceptibility. This phenomenon could be related to excessive use of quinolones and fluoroquinolones for the treatment or prevention of infectious diseases in pig husbandry in South China. Therefore, prudent measures for these agents' usage and active surveillance should be established.
Identification of PMQR genes
In this study, qnrA1, qnrB6 and aac(6 ′ )-Ib-cr, detected in H. parasuis for the first time, were present in 3 (2.61%), 1 (0.87%) and 3 (2.61%) isolates, respectively. The qnrA and qnrB amplicon sequences showed 100% identity to the reported qnrA1 and qnrB6 from Klebsiella pneumoniae plasmid pGDKA1 (GenBank accession number EU722351) and Shigella sonnei strain 136 (GenBank accession number GQ914054), respectively. The sequences for all of the amplicons of the aac(6 ′ )-Ib-cr fragment were indistinguishable and demonstrated 100% sequence identity to the reported aac(6 ′ )-Ib-cr from E. coli plasmid pEC_L8 (GenBank accession number GU371928). However, other PMQR genes (such as qnrS, qnrC, qnrD and qepA) were not found in these 115 isolates. Additionally, one strain was positive for both aac(6 ′ )-Ib-cr and qnrA1, and the MIC of ciprofloxacin was 16 mg/L. This strain awaits further study. To date, PMQR genes (qnrA, qnrB, qnrS, qnrD and qepA) have been reported in veterinary clinical isolates in China. 7, 8 Additionally, most qnr genes are located on a Tn-like sequence or integron in a conjugative plasmid, which has facilitated the rapid spread and increase in fluoroquinolone resistance in bacteria. 5 Thus, the dissemination of PMQR genes in the pig industry cannot be ignored and the mechanism of their spread in H. parasuis requires further study.
Analysis of QRDR mutations
In the present study, several QRDR mutations were found among resistant H. parasuis strains (Table 1) . It is worth noting that at least one mutation in gyrA was present in 20 resistant strains and 90% of isolates had two mutations in gyrA, but no gyrA mutations were found in the 15 reference strains. This finding suggests that gyrA mutations (S83Y, S83F, D87Y, D87N and D87G) are closely correlated with fluoroquinolone resistance in H. parasuis. The fluoroquinolone resistance levels of the strains with double gyrA mutations were higher than those with a single gyrA mutation, indicating that the increasing MICs of fluoroquinolones for H. parasuis are also associated with stepwise accumulation of gyrA mutations. parC mutations (Y577C, V648I, E678D, S669F, A464V and A466S) were found both in susceptible and resistant strains, indicating that these mutations are possibly not directly related to fluoroquinolone resistance of H. parasuis. In addition, parE mutations (S283G, A227T and G241S) were mainly found in qnr-positive strains in this study. Many previous studies have demonstrated that topoisomerase IV is the secondary target for fluoroquinolones, and a parC mutation related to fluoroquinolone resistance in other Gram-negative bacteria, such as Salmonella and E. coli, has been shown. 5, 6 However, Guo et al.
in A. pleuropneumoniae, parE mutation was possibly not involved in enrofloxacin resistance. 9 Thus, further studies are needed to evaluate whether parC and parE mutations are involved in fluoroquinolone resistance in H. parasuis. In contrast, gyrB mutations were not detected in this study. Overall, the QRDR analysis suggested that DNA gyrase (gyrA) is a primary target of fluoroquinolone resistance in H. parasuis, as in other Gram-negative bacteria. 5, 6, 9 This study also indicated that gyrA mutations (at codon 83 or 87) were related to fluoroquinolone resistance in H. parasuis.
PFGE
In this study, PFGE revealed great genomic heterogeneity among the 20 resistant isolates and PMQR-positive isolates [ Figure 1 and Figure S1 (available as Supplementary data at JAC Online)]. Of the 20 isolates, 3 isolates from different farms were clonally related ( Figure S1 ). Interestingly, one of the three clonally related strains carried a qnrA gene, which, along with the genetic diversity between the six PMQR-positive strains, indicates that the PMQR determinants may be obtained by each strain through transferable elements (such as plasmids, transposons etc.). So the spread of mechanisms of fluoroquinolone resistance in H. parasuis needs to be further investigated.
In conclusion, here, for the first time, we describe H. parasuis containing qnrA, qnrB and aac(6 ′ )-Ib-cr in South China. The data from this study suggest that fluoroquinolone resistance of H. parasuis is mainly due to the transferable PMQR determinants and multiple target gene mutations. These findings provide a 
GenBank accession numbers
The nucleotide sequences of qnr, aac(6 ′ )-Ib-cr and the variant gyrA genes reported here were deposited in the GenBank database with the accession numbers HQ117876-HQ117882 and HQ332468 -HQ332483.
